NEW YORK (GenomeWeb News) — MDS today reported that first-quarter revenue for its Sciex division increased 1.5 percent, though organic receipts increased 4 percent.
 
Total revenue for the three months ended Dec. 31, 2006, increased to $62 million from $61 million.
 
Driving revenue were the small molecule and applied markets and in Europe, MDS said.
 
MDS also said end-user revenue in the company’s joint ventures increased 10 percent.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

Futurism writes that gene doping could be the next generation of cheating in sports.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.